A Dual‐Targeting Strategy Against ROS and GSK‐3β With a PEGylated Fullerene/Smart Hydrogel Synergistic System for Diabetic Bone Regeneration
Advanced Materials · 2026
DOI: 10.1002/adma.202600033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Yijun Wang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Nanostructure and Nanotechnology & Beijing National Laboratory For Molecular Sciences, Institute of Chemistry, Chinese Ac…. Hauptthemen laut MEDLINE: Fullerenes, Bone Regeneration, Reactive Oxygen Species, Polyethylene Glycols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic bone regeneration remains a significant clinical challenge due to a hostile microenvironment characterized by oxidative stress and chronic inflammation. Here, we report a structurally defined, pentakis‐PEGylated fullerene derivative, termed FPEG 5 , which exhibits dual functionality as a potent reactive oxygen species (ROS) scavenger and an immunomodulator. Beyond its antioxidant activity, FPEG 5 directly targets glycogen synthase kinase‐3β (GSK‐3β), thereby stabilizing β‐catenin and suppressing the Nuclear Factor kappa‐B (NF‐κB) inflammatory axis. This dual‐action mechanism effectively reprograms macrophages from a pro‐inflammatory (M1) to a pro‐regenerative (M2) phenotype under diabetic conditions. To enable localized therapy, FPEG 5 is incorporated into an injectable, glucose‐ and ROS‐responsive hydrogel for on‐demand release. This combination effectively reshapes the local immune microenvironment, restores osteogenic differentiation in vitro, and drives robust, bridging bone regeneration in a diabetic calvarial defect model. This work presents a novel therapeutic strategy integrating a target‐specific fullerene pharmacophore with a smart delivery system for diabetic osteoregeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Molecular Nanostructure and Nanotechnology & Beijing National Laboratory For Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, P.R. China.
- University of Chinese Academy of Sciences, Beijing, P.R. China.
- Department of Dental Materials & Dental Medical Devices Testing Center, Peking University School and Hospital of Stomatology, Beijing, P. R. China.
- Department of Geriatric Dentistry, Peking University School and Hospital of Stomatology, Beijing, P.R. China.
- Beijing National Laboratory For Molecular Sciences, Laboratory of Polymer Physics and Chemistry, CAS Research/Education Center For Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, B…
- Ganzhou Key Laboratory For Drug Screening and Discovery, School of Geography and Environmental Engineering, Gannan Normal University, Ganzhou, Jiangxi, P.R. China.
ORCID-Profile: Chunru Wang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Li, J., Guo, Y., Li, B., Xu, L., Wang, Z., Yang, L., Zhang, W., Li, J., Liu, M., Wang, X., Chen, S., Zhang, Z., Liu, Y., Huo, J., Lu, Y., Cui, Q., Lu, Y., Zhang, X., …, & Bai, C. (2026). A Dual‐Targeting Strategy Against ROS and GSK‐3β With a PEGylated Fullerene/Smart Hydrogel Synergistic System for Diabetic Bone Regeneration. Advanced Materials. https://doi.org/10.1002/adma.202600033
Vancouver
Wang Y, Li J, Guo Y, Li B, Xu L, Wang Z, et al. A Dual‐Targeting Strategy Against ROS and GSK‐3β With a PEGylated Fullerene/Smart Hydrogel Synergistic System for Diabetic Bone Regeneration. Advanced Materials. 2026. doi:10.1002/adma.202600033
BibTeX
@article{Wang2026,
author = {Wang, Yijun and Li, Jie and Guo, Yusi and Li, Bowen and Xu, Liju and Wang, Zehu and Yang, Libin and Zhang, Weixin and Li, Jiao and Liu, Meihan and Wang, Xin and Chen, Shiliang and Zhang, Ziyi and Liu, Yang and Huo, Jiawei and Lu, Yixuan and Cui, Qun and Lu, Yanhui and Zhang, Xuehui and Wang, Chunru and Bai, Chunli},
title = {A Dual‐Targeting Strategy Against ROS and GSK‐3β With a PEGylated Fullerene/Smart Hydrogel Synergistic System for Diabetic Bone Regeneration},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202600033}
}
EUVIMED